2020年结直肠癌统计报告
美国癌症协会基于截至2016年的发病数据和截至2017年的死亡数据,更新了美国结直肠癌的发病与死亡情况。2020年预计新发147,950例、死亡53,200例;年轻人群发病率与死亡率上升,筛查年龄人群发病率趋势分化,死亡率整体下降但年轻人群上升。
要点
- 2020年美国预计结直肠癌新发147,950例,死亡53,200例。
- 50岁以下人群发病率约每年增加2%,死亡率每年增加1.3%。
- 65岁及以上人群发病率每年下降3.3%,死亡率每年下降3%。
核心结论
- 结直肠癌发病和死亡趋势在不同年龄和种族间存在差异,年轻人群发病率与死亡率上升。
- 增加指南推荐筛查的可及性和高质量治疗可加速结直肠癌防治进展。
研究设计与样本
- 美国癌症协会每3年更新的结直肠癌统计报告,基于截至2016年的发病数据和截至2017年的死亡数据。
- 发病数据来自基于人群的癌症登记处,死亡数据来自国家卫生统计中心。
主要发现
- 2020年预计147,950例新发结直肠癌和53,200例死亡,其中50岁以下人群17,930例新发和3,640例死亡。
- 2012至2016年发病率从亚太岛民的30/10万到黑人的45.7/10万和阿拉斯加原住民的89/10万不等。
- 2011至2016年65岁及以上人群发病率每年下降3.3%,50至64岁人群每年增加1%。
- 50岁以下人群近端结肠、远端结肠和直肠肿瘤发病率均约每年增加2%,主要由非西班牙裔白人趋势驱动。
- 2008至2017年65岁及以上人群死亡率每年下降3%,50至64岁人群每年下降0.6%,50岁以下人群每年增加1.3%。
临床怎么用
- 应关注年轻人群结直肠癌发病和死亡上升趋势,并提高指南推荐筛查的覆盖率。
- 针对阿拉斯加原住民等发病率高的群体,需加强筛查和治疗可及性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (available through 2016) from population-based cancer registries and mortality data (through 2017) from the National Center for Health Statistics. In 2020, approximately 147,950 individuals will be diagnosed with CRC and 53,200 will die from the disease, including 17,930 cases and 3,640 deaths in individuals aged younger than 50 years. The incidence rate during 2012 through 2016 ranged from 30 (per 100,000 persons) in Asian/Pacific Islanders to 45.7 in blacks and 89 in Alaska Natives. Rapid declines in incidence among screening-aged individuals during the 2000s continued during 2011 through 2016 in those aged 65 years and older (by 3.3% annually) but reversed in those aged 50 to 64 years, among whom rates increased by 1% annually. Among individuals aged younger than 50 years, the incidence rate increased by approximately 2% annually for tumors in the proximal and distal colon, as well as the rectum, driven by trends in non-Hispanic whites. CRC death rates during 2008 through 2017 declined by 3% annually in individuals aged 65 years and older and by 0.6% annually in individuals aged 50 to 64 years while increasing by 1.3% annually in those aged younger than 50 years. Mortality declines among individuals aged 50 years and older were steepest among blacks, who also had the only decreasing trend among those aged younger than 50 years, and excluded American Indians/Alaska Natives, among whom rates remained stable. Progress against CRC can be accelerated by increasing access to guideline-recommended screening and high-quality treatment, particularly among Alaska Natives, and elucidating causes for rising incidence in young and middle-aged adults.
引用
- Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020. PMID: 32133645. doi:10.3322/caac.21601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。